BIOMAT Database Logo BIOMAT Database Logo

[Bullous lesions in familial amyloid polyneuropathy and treatment with L-threo-3,4-dihydroxyphenylserine--with reference to peripheral circulation response against direct heat stimulation]. 1988

M Yazawa, and N Hanyu, and J Yoshioka, and A Nakadai, and N Yanagisawa

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010523 Peripheral Nervous System Diseases Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. Peripheral Nerve Diseases,Peripheral Neuropathies,PNS (Peripheral Nervous System) Diseases,PNS Diseases,Peripheral Nervous System Disease,Peripheral Nervous System Disorders,Nerve Disease, Peripheral,Nerve Diseases, Peripheral,Neuropathy, Peripheral,PNS Disease,Peripheral Nerve Disease,Peripheral Neuropathy
D010991 Plethysmography Recording of change in the size of a part as modified by the circulation in it. Plethysmographies
D005260 Female Females
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses
D012694 Serine A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids. L-Serine,L Serine

Related Publications

M Yazawa, and N Hanyu, and J Yoshioka, and A Nakadai, and N Yanagisawa
Orthostatic hypotension in familial amyloid polyneuropathy: treatment with DL-threo-3,4-dihydroxyphenylserine.
October 1981, Neurology,
M Yazawa, and N Hanyu, and J Yoshioka, and A Nakadai, and N Yanagisawa
Effect of infused L-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy.
June 1980, European journal of clinical pharmacology,
M Yazawa, and N Hanyu, and J Yoshioka, and A Nakadai, and N Yanagisawa
Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy.
January 1982, European journal of clinical pharmacology,
M Yazawa, and N Hanyu, and J Yoshioka, and A Nakadai, and N Yanagisawa
Intranasal L-threo-3,4,-dihydroxyphenylserine in treating diarrhea associated with familial amyloidotic polyneuropathy.
January 1995, Pharmacotherapy,
M Yazawa, and N Hanyu, and J Yoshioka, and A Nakadai, and N Yanagisawa
Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine.
January 1997, Journal of the autonomic nervous system,
M Yazawa, and N Hanyu, and J Yoshioka, and A Nakadai, and N Yanagisawa
Treatment of dialysis-induced hypotension with L-threo-3,4-dihydroxyphenylserine.
January 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M Yazawa, and N Hanyu, and J Yoshioka, and A Nakadai, and N Yanagisawa
Studies of neurocirculatory effects of long-term L-threo-3,4-dihydroxyphenylserine administration in a patient with familial amyloidotic polyneuropathy.
May 1988, Acta neurologica Scandinavica,
M Yazawa, and N Hanyu, and J Yoshioka, and A Nakadai, and N Yanagisawa
Treatment of parkinsonism with L-threo-3,4-dihydroxyphenylserine: a pharmacokinetic study.
November 1984, Neurology,
M Yazawa, and N Hanyu, and J Yoshioka, and A Nakadai, and N Yanagisawa
Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
March 1990, Japanese journal of pharmacology,
M Yazawa, and N Hanyu, and J Yoshioka, and A Nakadai, and N Yanagisawa
L-threo-3,4-dihydroxyphenylserine treatment for gait apraxia in parkinsonian patients.
January 1989, The Kurume medical journal,
Copied contents to your clipboard!